Enzon Pharmaceuticals, Inc. (ENZN) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Cranford, NJ, 美国. 现任CEO为 Richard L. Feinstein.
ENZN 拥有 IPO日期为 1984-02-15, 在 Other OTC, 市值为 $4.45M.
Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.
